Business
Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market Canada NewsWi...
About this update from Aurora Cannabis Inc.
[{"type":"text","content":"\n \n \n \n Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntar{\nTEXT-ALIGN: RIGHT\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n NASDAQ | TSX: ACB\n \n \n \n \n Canada's\n \n Leading Medical Cannabis Company Launches Prem\n \n \n ium Products Redefining Patient Care\n \n \n \n \n \n EDMONTON, AB\n \n \n ,\n \n \n May 8, 2024\n \n \n /CNW/ -\n \n Aurora Cannabis Inc.\n \n (NASDAQ: ACB) (TSX: ACB) the Canadian based leading global medical cannabis company, is proud to announce the arrival of Aurora branded medical cannabis products to the\n \n New Zealand\n \n market. This new line of premium dried flowers represents a significant milestone in medical cannabis accessibility in\n \n New Zealand\n \n , an emerging market poised for growth.\n \n \n \n \n \n \n \n \n \n The initial product portfolio includes cultivars grown exclusively by Aurora, with each strain meticulously bred and cultivated to address a variety of patient needs. These carefully crafted offerings reflect Aurora's commitment to providing prescribers and patients with unparalleled quality, potency\n \n ,\n \n and therapeutic benefits.\n \n \n \"As a global leader in medical cannabis, Aurora is proud to be at the forefront of advancing patient access in\n \n New Zealand\n \n with this first and meaningful product launch,\" said\n \n Miguel Martin\n \n , CEO, Aurora. \"We are thrilled to offer prescribers and patients premium dried flower options that embody our dedication to opening the world to cannabis while prioritizing patient care and well-being. We see great potential in the\n \n New Zealand\n \n market and intend to leverage symmetry with our leadership in\n \n Australia\n \n .\"\n \n \n Equiposa, the first balanced dried cannabis product in the market, is a testament to Aurora's commitment to providing diverse options to meet patient needs. This inaugural product offering from Aurora sets a new standard for medical cannabis in\n \n New Zealand\n \n , backed by uncompromised qu...